Sepharose-bound anti-immunoglobulins, which are potent mitogens for normal adult B cells, are not mitogenic for tumor cells freshly isolated from mice carrying the B-cell leukemia BCL1. However, after 4 or more days ofin vitro cultivation, BCL1 cells can be stimulated to divide by either anti-.I or anti-S antibodies. These MATERIALS AND METHODS BCL1 Tumor. The BCL1 tumor was maintained by in vivo passage in BALB/c mice (Cumberland Farms, Clinton, TN).
bodies. These 8 determinants can induce proliferation of spleen cells from adult mice (1) (2) (3) (4) (5) (6) (7) (8) (9) . In contrast, cells from neonatal mice or from adult immune-defective CBA/N mice do not proliferate in response to treatment with antibodies to Ig (8, 9) , suggesting that antiIgs are mitogenic for mature but not immature B cells. Treat The development ofa model system using a B-cell clone that could be activated into different states of differentiation would be of considerable advantage for the characterization of the molecular mechanisms underlying these events. Along these lines, there is a growing body ofevidence that neoplastic B lymphocytes, which are monoclonal in origin, can differentiate and respond to immunoregulatory signals (10). Fu et al. (11) originally observed that some patients with chronic lymphocytic leukemia had concomitant serum Ig ofthe idiotype present on their neoplastic B lymphocytes, suggesting that some ofthe leukemic cells had differentiated into Ig-secreting cells in vivo. It also has been shown (12, 13) that cultured peripheral blood lymphocytes of such patients could be induced to differentiate into Ig-secreting cells by the addition of mitogen or allogeneic T cells. Recently, T-cell factors have been substituted for allogeneic cells in these experiments (14) . It is noteworthy, however, that treatment of human leukemic cells with anti-Igs has not been shown to activate them (14) .
We have been studying the capacity of a murine B cell leu- MATERIALS AND METHODS BCL1 Tumor. The BCL1 tumor was maintained by in vivo passage in BALB/c mice (Cumberland Farms, Clinton, TN).
Culture Conditions. Peripheral blood lymphocytes (PBL) and spleen cells were prepared from mice that had carried the tumor >8 weeks and were cultured as described (6, 18) . Cells were cultured in flat-bottom 250-ml flasks (Falcon) at 2 X 106/ ml in RPMI-1640 with antibiotics and 5% fetal calf serum (GIBCO) in an atmosphere of83% N2J1O0% C02/7% 02 at 370C.
Neither 2-mercaptoethanol nor LPS was included during the initial incubation. At various times, cells were harvested from the cultures, the viability was determined (usually >90% for PBLs), and the cells were resuspended in fresh medium. The cells were then grown, in parallel with freshly prepared cells, in 200-pl flat-bottom microtiter wells (Linbro) with or without Sepharose-coupled antibodies (7) . When present, the concentration of2-mercaptoethanol was 50 gM; LPS (6) .
Antibodies. The preparation of affinity-purified rabbit antibodies against A and 8 heavy chains, light chain, and the hybridoma antibody (anti-S, H 10.4.22) has been described (20) ; the control myeloma protein RPC-5 (IgG2a) was purchased from Litton Bionetics (Kensington, MD). Antibodies were covalently coupled to cyanogen bromide-activated Sepharose 4B at 1 mg of antibody per ml of Sepharose. Mouse anti-idiotype was generated by immunizing C57BL/6 mice with the IgM, purified from the ascites of mice bearing the BCLI-X63 hybridoma (21) . Antibody activity against the Au allotype was removed by adsorption on Sepharose-MOPC-104E. The IgG fraction was prepared on DEAE-Sephadex A50. The mouse anti-idiotype was shown to be idiotype-specific by its ability to bind IgM from the BCL1 cells but not from normal BALB/c splenocytes ( Fig. 1) .
T-Cell Supernatants. Mixed lymphocyte culture (MLC). Spleen cells (107/ml) from BALB/c mice were cocultured with an equal number of irradiated C57BL/6 splenocytes for 48 hr in RPMI-1640 with 7.5% fetal calf serum and 50 AM 2-mercaptoethanol. Cell-free supernatants were obtained by centrifugation and filtration (0.45-,um Nalgene membrane) of pooled cultures; 50-75 1l of supernatant was used in 200-,ul cultures. Con A pulse. Spleen cells (107/ml) from BALB/c mice were incubated in the presence ofCon A (8 ,ug/ml) for 2 hr. The cells were harvested, washed twice in balanced salt solution, and recultured in RPMI-1640 (supplemented as described above) for 36 hr. Cell-free supernatants were obtained as described above. RESULTS Effect of Sepharose-Coupled Anti-Igs on Proliferation. Sepharose-coupled anti-,u, which is a potent mitogen for murine spleen cells (7), had no effect on BCL, cells under several different experimental conditions (Fig. 2 Left) . This observation is similar to findings with splenocytes from neonatal mice (7-10 days of age) which do not respond to Sepharose-anti-Igs (9) and, hence, provides further evidence that BCL1 cells are analogous to immature B cells (15) . In contrast, after cultivation in vitro, BCL1 cells responded to Sepharose-anti-,u with a dose-dependent increase in [3H]thymidine incorporation ( Fig. 2 Right) ; Sepharose-coupled antibodies against 8 (both hybridoma and rabbit) were equally mitogenic, in accord with previous results with spleen cells from adult mice (7). The optimal dose observed for BCLI cells was also similar to that found with normal adult B cells (7) . Background [3H]thymidine incorporation declined steadily with increasing time of preculture whereas the magnitude of the response to LPS was unchanged (data not shown). Interestingly, the mitogenic response to 2-mercaptoethanol, which is often high in uncultured PBL (6, 17) , also decreased progressively with time of preculture.
Similar results were obtained when spleen cells, rather than PBL, from BCLI-bearing mice were used (data not shown).
However, recovery of spleen cells from the primary culture usually was poor and therefore PBL were used for most experiments. We have also found that soluble F(ab')2 rabbit anti-p. is mitogenic for the precultured cells (data not shown), in marked contrast to its inhibitory effects for uncultured cells (6) . Kinetics ofthe Acquisition ofResponsiveness by BCL1 Cells. We next investigated the length of time in culture necessary to obtain a mitogenic response to the Sepharose anti-Igs. No stimulation was observed after 2 days of preculture; responses to both anti-,u and anti-8 first appeared after 4 days and continued to increase thereafter (Fig. 3) . These data were obtained by using 2-mercaptoethanol in the medium; however, equivalent results were observed in its absence (i.e., no stimulation by antiIgs without a minimum of 4 days of preculture). Sepharose-Ig, ,ug/ml (Fig. 4) it is possible that changes in membrane fluidity or the state of activation of the cytoskeleton could be responsible for the acquisition of responsiveness. A similar refractoriness to capping has been described in chronic lymphocytic leukemia cells freshly harvested from human peripheral blood (24, 25) .
The precise role of sIg in signaling B lymphocytes has been controversial (10 (28) . Interleukin-2 is a growth factor that stimulates proliferation whereas T-cell-replacing factor appears to be a distinct factor that causes terminal differentiation (28) . It is possible that freshly harvested BCL1 cells (or splenocytes from neonatal animals) after interaction with anti-Ig display receptors for T-cell-replacing factor but not interleukin-2, whereas precultured BCL1 cells can display receptors for both T-cell factors after activation by anti-Ig. The recent preparation of hybridomas that secrete these two T-cell factors (29, 30) and the monoclonality of BCL1 will aid in testing this hypothesis.
Note Added in Proof. In recent experiments we have found that supernatants from T-cell lines producing T-cell replacing factor(s) (30) can induce Ig secretion (by BCL1 or normal B cells) in the absence of antiIgs. These cell lines appear to produce a less-heterogeneous population ofT-cell factors than is present in Con A or MLC supernatants prepared from spleen cells (30) .
